Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
57.30
-0.88 (-1.52%)
At close: Jul 20, 2026, 4:00 PM EDT
57.10
-0.20 (-0.34%)
After-hours: Jul 20, 2026, 7:34 PM EDT
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $32.99 billion as of July 20, 2026. Its market cap has increased by 64.88% in one year.
Market Cap
32.99B
Enterprise Value
41.36B
1-Year Change
64.88%
Ranking
Category
Stock Price
$57.30
ChartMarket Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from $26.49B to $32.99B, an increase of 24.53%. That is a compound annual growth rate of 3.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 32.99B | 47.92% |
| Dec 31, 2025 | 22.30B | 48.40% |
| Dec 31, 2024 | 15.03B | -10.44% |
| Dec 29, 2023 | 16.78B | -30.07% |
| Dec 30, 2022 | 24.00B | -0.82% |
| Dec 31, 2021 | 24.20B | -20.37% |
| Dec 31, 2020 | 30.39B | 14.69% |
| Jun 16, 2020 | 26.49B | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Regeneron Pharmaceuticals | 68.85B |
| argenx SE | 53.83B |
| Revolution Medicines | 39.58B |
| Alnylam Pharmaceuticals | 35.71B |
| BeOne Medicines AG | 34.69B |
| Roivant Sciences | 24.82B |
| Moderna | 24.53B |
| Insmed | 23.48B |